Literature DB >> 7588244

Molecular basis of estrogen regulation of Hageman factor XII gene expression.

A Farsetti1, S Misiti, F Citarella, A Felici, M Andreoli, A Fantoni, A Sacchi, A Pontecorvi.   

Abstract

Estrogen therapy has been reported to cause multiple alterations in hemostasis and to increase blood levels of several procoagulants, including Hageman factor [factor XII (FXII)]. Liver FXII gene expression has been investigated in ovariectomized rats, treated or not with 17 beta-estradiol. A 6-fold stimulation of FXII gene transcription was observed in treated compared to untreated animals, indicating that 17 beta-estradiol is able to induce FXII gene expression in vivo. We have recently shown that human FXII promoter contains an imperfect palindrome, 5'-GGGCAnnnTGACC-3', at position -43/-31 resembling the consensus estrogen-responsive element (ERE). Portions of different length of the FXII promoter were fused to the chloramphenicol acetyltransferase (CAT) coding sequence and transiently cotransfected with human estrogen receptor (ER) into NIH3T3 and HepG2 cells in the presence or absence of 17 beta-estradiol. A 230-base pair fragment of FXII promoter, spanning nucleotides - 181/49, conferred a strong estrogen responsiveness to the CAT reporter gene, suggesting that a functional ERE resides in this region. Cognate receptors, such as those for thyroid hormone or retinoic acid, did not stimulate CAT activity. Gel mobility assays demonstrated a specific interaction between ER and the 230-bp FXII promoter fragment containing the putative ERE palindrome. Similar results were obtained when an oligonucleotide spanning the consensus ERE was used; the complex between ER and FXII promoter sequences was supershifted after the addition of an anti-ER monoclonal antibody. Insertion of FXII-ERE into the heterologous thymidine kinase promoter conferred a strong estrogen responsiveness that was abolished by mutations of the 5'-half of the palindrome. These results represent the first demonstration at the molecular level of the regulation of a blood coagulation factor gene by 17 beta-estradiol as well as the first identification of a functional ERE within this class of genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588244     DOI: 10.1210/endo.136.11.7588244

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

1.  Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Authors:  Angelo Agostoni; Emel Aygören-Pürsün; Karen E Binkley; Alvaro Blanch; Konrad Bork; Laurence Bouillet; Christoph Bucher; Anthony J Castaldo; Marco Cicardi; Alvin E Davis; Caterina De Carolis; Christian Drouet; Christiane Duponchel; Henriette Farkas; Kálmán Fáy; Béla Fekete; Bettina Fischer; Luigi Fontana; George Füst; Roberto Giacomelli; Albrecht Gröner; C Erik Hack; George Harmat; John Jakenfelds; Mathias Juers; Lajos Kalmár; Pál N Kaposi; István Karádi; Arianna Kitzinger; Tímea Kollár; Wolfhart Kreuz; Peter Lakatos; Hilary J Longhurst; Margarita Lopez-Trascasa; Inmaculada Martinez-Saguer; Nicole Monnier; István Nagy; Eva Németh; Erik Waage Nielsen; Jan H Nuijens; Caroline O'grady; Emanuela Pappalardo; Vincenzo Penna; Carlo Perricone; Roberto Perricone; Ursula Rauch; Olga Roche; Eva Rusicke; Peter J Späth; George Szendei; Edit Takács; Attila Tordai; Lennart Truedsson; Lilian Varga; Beáta Visy; Kayla Williams; Andrea Zanichelli; Lorenza Zingale
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

2.  Specific adaptations of estrogen receptor alpha and beta transcripts in liver and heart after endurance training in rats.

Authors:  Amélie Paquette; Dongaho Wang; Marie-Soleil Gauthier; Denis Prud'homme; Marek Jankowski; Jolanta Gutkowska; Jean-Marc Lavoie
Journal:  Mol Cell Biochem       Date:  2007-08-01       Impact factor: 3.396

3.  Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012.

Authors:  Markus Magerl; Michael Bader; Anne Gompel; Kusumam Joseph; Allen P Kaplan; Georg Kojda; Thomas Renné; Markus Wirth; Marcus Maurer; Martin K Church
Journal:  Inflamm Res       Date:  2013-12-08       Impact factor: 4.575

Review 4.  Wolf in the sheep's clothing: intestinal angioedema mimicking infectious colitis.

Authors:  Asif Mehmood; Hafez Mohammad Ammar Abdullah; Faisal Inayat; Waqas Ullah
Journal:  BMJ Case Rep       Date:  2018-12-13

Review 5.  Sex differences in stroke: the contribution of coagulation.

Authors:  Meaghan Roy-O'Reilly; Louise D McCullough
Journal:  Exp Neurol       Date:  2014-02-19       Impact factor: 5.330

Review 6.  Hereditary angioedema in childhood: an approach to management.

Authors:  Didier G Ebo; Marjoke M Verweij; Kathleen J De Knop; Margo M Hagendorens; Chris H Bridts; Luc S De Clerck; Wim J Stevens
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

7.  Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells.

Authors:  S Misiti; S Nanni; G Fontemaggi; Y S Cong; J Wen; H W Hirte; G Piaggio; A Sacchi; A Pontecorvi; S Bacchetti; A Farsetti
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 8.  HAE Pathophysiology and Underlying Mechanisms.

Authors:  Bruce L Zuraw; Sandra C Christiansen
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 9.  Managing the female patient with hereditary angioedema.

Authors:  Aleena Banerji; Marc Riedl
Journal:  Womens Health (Lond)       Date:  2016-03-15

10.  Obstetrical Complications and Outcome in Two Families with Hereditary Angioedema due to Mutation in the F12 Gene.

Authors:  Olivier Picone; Anne-Claire Donnadieu; François G Brivet; Catherine Boyer-Neumann; Véronique Frémeaux-Bacchi; René Frydman
Journal:  Obstet Gynecol Int       Date:  2010-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.